TARPLIN, DOWNS & YOUNG, LLC

Lobbying for BRISTOL MYERS SQUIBB · Global biopharma company developing innovative medicines

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · New York · House · Senate · $80,000.00 income · posted Jan 20, 2026

Lobbying activity 3

Medicare/Medicaid

IRA, Medicare & Medicaid payment and coverage issues

Health Issues

prescription drug access and affordability, pricing, transparency, drug pricing in federal programs

Budget/Appropriations

federal budget issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.